The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A UGT1A1 *28 and *6 genotype-directed phase I study of irinotecan plus infusional leucovorin and 5-fluorouracil (sLV5FU2) in patients with previously untreated metastatic colorectal cancer (mCRC).
Yong Sang Hong
No relevant relationships to disclose
Kyu-Pyo Kim
No relevant relationships to disclose
Jae-Lyun Lee
No relevant relationships to disclose
Kyun Seop Bae
No relevant relationships to disclose
Ho-Sook Kim
No relevant relationships to disclose
Jae-Gook Shin
No relevant relationships to disclose
Jung Shin Lee
No relevant relationships to disclose
Tae Won Kim
No relevant relationships to disclose